Skip to main content

Find Clinical Trials

Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Completed

A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)

NCT00988884

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

NCT02269943

Conditions: Carcinoma, DNA Virus Infections, Disease Attributes, +23 more
Locations: Winship Cancer Institute of Emory University Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Columbia Comprehensive Cancer Care Clinic Jefferson City, Missouri, United States

View all 25 locations

View Trial Details

Completed

A Study of A-101 Solution in Subjects With Common Warts.

NCT02669862

Conditions: Common Warts, DNA Virus Infections, Infections, +8 more
Locations: Aclaris Therapeutics, Inc. Wayne, Pennsylvania, United States

View Trial Details

Completed

A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008).

NCT01254643

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +21 more
Locations: Not specified

View Trial Details

Completed

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

NCT00543543

Conditions: Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +36 more
Locations: Not specified

View Trial Details

Completed

A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)

NCT01073293

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations: Not specified

View Trial Details

Completed

A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

NCT01047345

Conditions: Cervical Cancers, Communicable Diseases, Condylomata Acuminata, +35 more
Locations: Not specified

View Trial Details

Completed

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

NCT01651949

Conditions: Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +32 more
Locations: Not specified

View Trial Details

Completed

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00003245

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +36 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

NCT01245764

Conditions: Communicable Diseases, Condylomata Acuminata, DNA Virus Infections, +31 more
Locations: Not specified

View Trial Details